Extrapulmonary neuroendocrine carcinoma (EP-NEC) is a rare and aggressive cancer that is often misunderstood and diagnosed late.
In this video for patients and care partners, Jessica Thomas, Director of Patient Education at the Neuroendocrine Tumour Research Foundation, highlights why specialist care is essential for people with EP-NEC. She introduces the concept of “thrivership” and explains how finding the right support can help with informed decision-making and values-aligned care.
Jessica emphasises the importance of expert treatment and connection with advocacy organisations, and explores the possibilities offered by evolving therapeutic options.
Clinical takeaways
- EP-NEC is a distinct and aggressive subtype of neuroendocrine cancer, characterised by late diagnosis, frequent mis-categorisation, and mis-understanding
- Delays in diagnosis, inconsistent treatment pathways, limited specialist access, and patient confusion underscore the complexity and burden of EP-NEC
- Given the complexity of EP-NEC, patients require expert care from specialists knowledgeable in neuroendocrine carcinoma, as generic care is insufficient to address the aggressive nature and unique challenges of this disease
- Thrivership in the context of EP-NEC includes finding agency around the things that can be controlled, understanding the disease, the urgency of diagnosis and management, and evolving treatment options



5 MIN
Dec 2025
Downloadable
